Published in Biomed Res Int on September 28, 2015
Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci U S A (2008) 2.47
Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Urol Oncol (2013) 1.78
ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (2012) 1.28
Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol (2008) 1.02
New insights into prostate cancer stem cells. Cell Cycle (2013) 1.02
Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol Ther (2012) 0.99
Prostate cancer stem cells. Clin Genitourin Cancer (2012) 0.96
Targeting the androgen receptor. Urol Clin North Am (2012) 0.92
Increase of gap junction activities in SW480 human colorectal cancer cells. BMC Cancer (2014) 0.91
Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J Sex Med (2011) 0.91
Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT. Oncol Rep (2014) 0.91
Prognostic value of connexin43 expression in patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis (2010) 0.90
Androgen excess down-regulates connexin43 in a human granulosa cell line. Fertil Steril (2010) 0.87
Pathological implications of Cx43 down-regulation in human colon cancer. Asian Pac J Cancer Prev (2014) 0.85
Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate. Biomed Res Int (2015) 0.75